HIV drug resistance in adults receiving early versus delayed antiretroviral therapy: HPTN 052

INTRODUCTION: We evaluated HIV drug resistance in adults who received early versus delayed antiretroviral therapy (ART) in a multi-national trial (HPTN 052, enrollment 2005–2010). In HPTN 052, 1,763 index participants were randomized to start ART at a CD4 cell count of 350–550 cells/mm(3) (early ART...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Acquir Immune Defic Syndr
Asıl Yazarlar: Palumbo, Philip J., Fogel, Jessica M., Hudelson, Sarah E., Wilson, Ethan A., Hart, Stephen, Hovind, Laura, Piwowar-Manning, Estelle, Wallis, Carole, Papathanasopoulos, Maria A., Morgado, Mariza G., Saravanan, Shanmugam, Tripathy, Srikanth, Eron, Joseph J., Gallant, Joel E., McCauley, Marybeth, Gamble, Theresa, Hosseinipour, Mina C., Kumarasamy, Nagalingeswaran, Hakim, James G., Pilotto, Jose H., Kumwenda, Johnstone, Akelo, Victor, Godbole, Sheela V., Santos, Breno R., Grinsztejn, Beatriz, Panchia, Ravindre, Chariyalertsak, Suwat, Makhema, Joseph, Badal-Faesen, Sharlaa, Chen, Ying Q., Cohen, Myron S., Eshleman, Susan H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844834/
https://ncbi.nlm.nih.gov/pubmed/29293156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001623
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller